R
ResMed Inc. (RMD)
NYQ – Real Time Price. Currency in USD
203.79
+5.03 (2.53%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NYQ – Real Time Price. Currency in USD
203.79
+5.03 (2.53%)
At close: May 12, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 3.01 | 3.39 | 10 | |
| Quick ratio | 2.33 | 2.51 | 10 | |
| Debt to Equity | 0.13 | 0.29 | 9.0 | |
| Debt to Assets | 0.10 | 0.62 | 9.0 | |
| Interest coverage | N/A | 24.85 | 10 | |
| Weighted average score | 9.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 3.58B | 4.22B | 4.69B | 5.15B | 5.54B |
| Gross Profit | 1.99B | 2.31B | 2.61B | 3.01B | 3.36B |
| Operating Income | 1B | 1.15B | 1.38B | 1.69B | 1.92B |
| Net Income | 779M | 898M | 1.02B | 1.40B | 1.52B |
| EBITDA | 1.19B | 1.35B | 1.60B | 1.92B | 2.19B |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 8.71 | 13.46 | 7.0 |
| Next quarter | 7.63 | 12.49 | 6.5 |
| Current year | 9.8 | 16.32 | 7.5 |
| Next year | 7.56 | 10.16 | 6.5 |
| Weighted average score | 6.9 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 0.6 | 1.56 | 1.78 | 67.25 | 4.5 |
| Y/Y | 10.81 | 9.23 | 20.68 | -6.69 | 6.0 |
| 3y average | 12.94 | 22.03 | 18.27 | 106.59 | 9.3 |
| 5y average | 11.77 | 21.34 | 15.08 | 48.72 | 9.0 |
| Weighted average score | 7.2 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.88 | 0.88 | 4.0 |
| Payout ratio | 21.94 | 21.94 | 4.0 |
| 5-year dividend growth rate | 7.70 | 7.70 | 8.0 |
| Years of dividend increase | 14.00 | 14.00 | 8.0 |
| Weighted average score | 6.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | Medium | 7.0 |
| Intangible assets | Medium | 7.0 |
| Switching costs | Medium | 6.0 |
| Network effect | Narrow | 2.0 |
| Economies of scale | Medium | 6.0 |
| Weighted average score | 5.6 | |
Company's cash reserves $1.7B significantly exceed its total debt $843.2M, ensuring strong financial flexibility
Total current assets $4.1B exceed Total current liabilities $1.4B, highlighting excellent liquidity
Debt-to-equity ratio (0.1) is well below the industry average (0.3), showcasing prudent financial management
The company has no interest-bearing debt, showcasing excellent financial strength
The company generates positive free cash flow $520.5M, supporting its financial health